Nasdaq:INVA
Innoviva, Inc.
A premier additive manufacturing technology firm delivering high-performance materials for industrial 3D printing solutions.
Key Metrics
Investment Thesis
Bull Case
Investors should consider INVA due to its powerful reversion-to-mean earnings profile where 2025 profits suggest the stock may be undervalued relative to current fundamentals. The company's massive cash hoard of $550.9M allows for aggressive reinvestment in R&D and potential share buybacks, potentially boosting per-share value over time. As a niche leader in high-performance 3D printing materials, Innoviva is well-positioned to capture growing demand from industrial manufacturers seeking lightweight, complex parts.
Bear Case
The stock carries elevated valuation risk given the volatility seen in net income, which swung dramatically between $23.4M and $271.2M within a two-year span. High levels of amortization ($26.3M) and interest expenses ($16.7M) significantly reduce reported earnings quality compared to cash flow metrics. Potential regulatory hurdles for chemical products combined with competitive pricing pressure from generic substitutes could erode the company's premium margins.
About Innoviva, Inc.
Innoviva (INVA) is a leading provider of proprietary technologies for additive manufacturing, primarily serving industrial sectors with high-performance materials. The company focuses on developing advanced polymers and resins for 3D printing applications in aerospace, automotive, and dental markets. With strong cash flow generation and significant growth in recent years, Innoviva aims to expand its global footprint and product portfolio.
Analysis
Management Discussion
The company demonstrated exceptional financial recovery in 2025 with net income surging to $271.2M compared to just $23.4M the prior year, reversing previous volatility. Revenue growth accelerated to $411.3M in 2025 from $358.7M in 2024, driven by successful product launches and expanding market adoption of their advanced resin technologies. Cash flow from operations remains robust at $196.9M, providing ample liquidity despite high amortization charges related to acquired intangible assets.
Industry Overview
The global 3D printing industry is experiencing rapid expansion, particularly in industrial applications where traditional manufacturing methods face limitations in complexity and waste reduction. Innoviva operates within this high-growth sector providing specialized materials that enable faster prototyping and production for aerospace and automotive industries. Regulatory frameworks are evolving to address safety concerns around new chemical substances, creating both barriers to entry and opportunities for compliant leaders.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $331.3M | $310.5M | $358.7M | $411.3M |
| Cost of Revenue | $0 | $0 | $0 | $103.7M |
| Gross Profit | $331.3M | $310.5M | $358.7M | $307.7M |
| Operating Expenses | $44.4M | $116.4M | $321.3M | $143.9M |
| Operating Income | $286.9M | $194.1M | $37.4M | $163.7M |
| R&D | $41.4M | $33.9M | $13.7M | $30.6M |
| G&A | $63.5M | $98.2M | $115.7M | $113.3M |
| Stock-Based Comp | $7.3M | $5.8M | $6.4M | $9.5M |
| Amortization | $5.6M | $21.8M | $25.9M | $26.3M |
| Other OpEx | $-60.6M | $-15.8M | $192.0M | $0 |
| Non-Operating Income | $0 | $0 | $0 | $163.1M |
| Interest Expense | $15.8M | $19.2M | $22.2M | $16.7M |
| Pre-Tax Income | $286.9M | $194.1M | $37.4M | $326.9M |
| Income Tax | $66.7M | $14.4M | $14.0M | $55.7M |
| Continuing Ops | $220.3M | $179.7M | $23.4M | $271.2M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $220.3M | $179.7M | $23.4M | $271.2M |
| Minority Interest | $6.3M | $0 | $0 | $0 |
| Net to Common | $213.9M | $179.7M | $23.4M | $271.2M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $443.5M | $344.2M | $554.3M | $727.5M |
| Cash & Equivalents | $291.0M | $193.5M | $305.0M | $550.9M |
| Inventory | $55.9M | $40.7M | $33.7M | $39.2M |
| Prepaid Expenses | $29.6M | $21.6M | $21.1M | $26.7M |
| Other Current Assets | $67.0M | $88.3M | $194.6M | $110.7M |
| Long-Term Assets | $788.0M | $899.3M | $746.8M | $907.6M |
| PP&E (Net) | $170.0K | $483.0K | $514.0K | $1.6M |
| Intangibles | $252.9M | $230.3M | $208.4M | $182.2M |
| Goodwill | $26.7M | $17.9M | $17.9M | $17.9M |
| Operating Leases | $3.3M | $2.5M | $2.5M | $10.9M |
| LT Investments | $403.0M | $444.4M | $341.7M | $404.5M |
| Other LT Assets | $101.9M | $203.6M | $175.8M | $290.6M |
| Total Assets | $1.23B | $1.24B | $1.30B | $1.64B |
| Current Liabilities | $135.0M | $38.1M | $236.1M | $49.7M |
| Accounts Payable | $2.9M | $6.7M | $2.1M | $5.0M |
| Current Leases | $1.3M | $1.2M | $1.6M | $418.0K |
| Taxes Payable | $154.0K | $0 | — | $274.0K |
| Other Current Liab | $130.6M | $30.2M | $232.4M | $44.0M |
| Long-Term Liabilities | $530.7M | $530.4M | $373.8M | $412.6M |
| Long-Term Debt | $444.2M | $446.2M | $256.3M | $257.7M |
| LT Operating Leases | $2.4M | $1.6M | $1.2M | $10.9M |
| Other LT Liab | $84.2M | $82.5M | $63.1M | $87.0M |
| Total Liabilities | $665.7M | $568.6M | $609.9M | $462.3M |
| Shareholders' Equity | $565.8M | $675.0M | $691.2M | $1.17B |
| Retained Earnings | $-204.9M | $-25.2M | $-1.8M | $269.4M |
| Total L&E | $1.23B | $1.24B | $1.30B | $1.64B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $220.3M | $179.7M | $23.4M | $271.2M |
| Non-Cash Adjustments | $-54.6M | $-68.0M | $78.8M | $-103.3M |
| Working Capital Changes | $36.1M | $29.3M | $86.5M | $29.1M |
| Cash from Operations | $201.7M | $141.1M | $188.7M | $196.9M |
| Capital Expenditures | $67.0K | $411.0K | $270.0K | $1.1M |
| Cash from Investing | $-56.6M | $-66.8M | $-63.8M | $40.5M |
| Share Buybacks | $8.5M | $75.7M | $14.8M | $4.5M |
| Cash from Financing | $-55.6M | $-171.8M | $-13.5M | $8.6M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $89.5M | $-97.5M | $111.5M | $246.0M |
| Beginning Cash | $201.5M | $291.0M | $193.5M | $305.0M |
| Ending Cash | $291.0M | $193.5M | $305.0M | $550.9M |
Frequently Asked Questions
How does Innoviva, Inc. make money?
Revenue is driven by the sale of proprietary photopolymers and resins used in stereolithography (SLA) and digital light processing (DLP) 3D printers, alongside licensing fees and royalties from partner technologies. Key revenue streams include direct material sales to industrial clients and strategic partnerships that generate recurring royalty income.
What are the main risks for INVA?
Regulatory scrutiny regarding the safety and environmental impact of proprietary chemical resins could impact market access or require costly compliance upgrades. Intense competition from larger chemical conglomerates entering the 3D printing space with lower-cost generic materials poses a margin compression threat. Dependence on a few large industrial customers for a significant portion of revenue creates concentration risk if any major client reduces orders.
What is INVA's competitive advantage?
The company holds a dominant market position through its proprietary chemistry patents which offer superior print quality and mechanical properties compared to generic alternatives. Innoviva benefits from a high switching cost moat as customers integrate its specific resin formulations into complex manufacturing workflows, ensuring customer retention. Strong balance sheet with $550.9M in cash provides significant flexibility for R&D investment and strategic acquisitions without dilution risk.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.